世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000037982

細胞凍結保存市場 -2032年までの予測

Market Research Future

Cell Cryopreservation Market- Forecast till 2032

発刊日 2024/04

言語英語

体裁PDF/128ページ

ライセンス/価格128ページ

0000037982

Single
Multiuser
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

世界の細胞凍結保存市場調査レポート:タイプ別情報 (細胞凍結培地、装置、消耗品など)、用途別(幹細胞、卵母細胞、精子細胞など)、エンドユーザー別 (製薬・バイオテクノロジー企業、研究機関、バイオバンク、体外受精クリニックなど)、地域別 (北米、欧州、アジア太平洋、その他の地域) -2032年までの市場予測

細胞凍結保存市場の概要

細胞凍結保存市場は、2022年に72億ドルと評価されました。この市場は、2023年の88億ドルから2032年には463億ドルに成長し、予測期間中に23.00%のCAGRを示すと予測されます。バイオバンキングにおける活動の拡大、細胞治療の進歩、幹細胞に関する研究の増加が、市場の成長を促進する主な要因です。

レポート詳細

目次

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations

3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation

4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities

5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis

6. GLOBAL CELL CRYOPRESERVATION MARKET, BY TYPE
6.1. Overview
6.2. Cell Freezing Media
6.3. Equipment
6.4. Consumables
6.5. Others

7. GLOBAL CELL CRYOPRESERVATION MARKET, BY APPLICATION
7.1. Overview
7.2. Stem Cells
7.3. Oocytes Cells
7.4. Sperm Cells
7.5. Others

8. GLOBAL CELL CRYOPRESERVATION MARKET, BY END USER
8.1. Overview
8.2. Pharmaceutical and Biotechnology Company
8.3. Research Institute
8.4. Biobanks
8.5. IVF Clinics
8.6. Others

9. GLOBAL CELL CRYOPRESERVATION MARKET, BY REGION
9.1. Overview
9.1. North America
9.1.1. US
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. France
9.2.3. UK
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. South Korea
9.3.5. Australia
9.3.6. Rest of Asia-Pacific
9.4. Rest of the World
9.4.1. Middle East
9.4.2. Africa
9.4.3. Latin America

10. COMPETITIVE LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global Cell Cryopreservation Market,
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Global Cell Cryopreservation Market,
10.7. Key Developments and Growth Strategies
10.7.1. New Product Launch/Service Deployment
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales & Operating Income, 2023
10.8.2. Major Players R&D Expenditure. 2023

11. COMPANY PROFILES
11.1. Thermo Fisher Scientific Inc.
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Products Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. VWR International LLC
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Products Offered
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. STEMCELL Technologies Inc.
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Products Offered
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. Merck KGaA
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Products Offered
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. GE Healthcare Life Sciences
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Products Offered
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. BioLife Solutions Inc.
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Products Offered
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. Avantor Inc.
11.7.1. Company Overview
11.7.2. Financial Overview
11.7.3. Products Offered
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. Biocision LLC
11.8.1. Company Overview
11.8.2. Financial Overview
11.8.3. Products Offered
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. Cesca Therapeutics Inc.
11.9.1. Company Overview
11.9.2. Financial Overview
11.9.3. Products Offered
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. Chart Industries Inc.
11.10.1. Company Overview
11.10.2. Financial Overview
11.10.3. Products Offered
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies
11.11. Custom Biogenic Systems Inc.
11.11.1. Company Overview
11.11.2. Financial Overview
11.11.3. Products Offered
11.11.4. Key Developments
11.11.5. SWOT Analysis
11.11.6. Key Strategies
11.12. Worthington Industries Inc.
11.12.1. Company Overview
11.12.2. Financial Overview
11.12.3. Products Offered
11.12.4. Key Developments
11.12.5. SWOT Analysis
11.12.6. Key Strategies
11.13. Hamilton Company
11.13.1. Company Overview
11.13.2. Financial Overview
11.13.3. Products Offered
11.13.4. Key Developments
11.13.5. SWOT Analysis
11.13.6. Key Strategies
11.14. Becton, Dickinson and Company
11.14.1. Company Overview
11.14.2. Financial Overview
11.14.3. Products Offered
11.14.4. Key Developments
11.14.5. SWOT Analysis
11.14.6. Key Strategies
11.15. Brooks Automation Inc.
11.15.1. Company Overview
11.15.2. Financial Overview
11.15.3. Products Offered
11.15.4. Key Developments
11.15.5. SWOT Analysis
11.15.6. Key Strategies
11.16. ZENOAQ RESOURCE CO. LTD.
11.16.1. Company Overview
11.16.2. Financial Overview
11.16.3. Products Offered
11.16.4. Key Developments
11.16.5. SWOT Analysis
11.16.6. Key Strategies
11.17. Aivita Biomedical
11.17.1. Company Overview
11.17.2. Financial Overview
11.17.3. Products Offered
11.17.4. Key Developments
11.17.5. SWOT Analysis
11.17.6. Key Strategies

12. APPENDIX
12.1. References
12.2. Related Reports

LIST OF TABLES
TABLE 1 GLOBAL CELL CRYOPRESERVATION MARKET, SYNOPSIS, 2019-2032
TABLE 2 GLOBAL CELL CRYOPRESERVATION MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)
TABLE 3 GLOBAL CELL CRYOPRESERVATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 4 GLOBAL CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 5 GLOBAL CELL CRYOPRESERVATION MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 6 NORTH AMERICA: CELL CRYOPRESERVATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 7 NORTH AMERICA: CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 8 NORTH AMERICA: CELL CRYOPRESERVATION MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 9 US: CELL CRYOPRESERVATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 10 US: CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 11 US: CELL CRYOPRESERVATION MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 12 CANADA: CELL CRYOPRESERVATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 13 CANADA: CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 14 CANADA: CELL CRYOPRESERVATION MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 1 EUROPE: CELL CRYOPRESERVATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 2 EUROPE: CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 3 EUROPE: CELL CRYOPRESERVATION MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 4 GERMANY: CELL CRYOPRESERVATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 5 GERMANY: CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 6 GERMANY: CELL CRYOPRESERVATION MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 7 FRANCE: CELL CRYOPRESERVATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 8 FRANCE: CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 9 FRANCE: CELL CRYOPRESERVATION MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 10 ITALY: CELL CRYOPRESERVATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 11 ITALY: CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 12 ITALY: CELL CRYOPRESERVATION MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 13 SPAIN: CELL CRYOPRESERVATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 14 SPAIN: CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 15 SPAIN: CELL CRYOPRESERVATION MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 16 UK: CELL CRYOPRESERVATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 17 UK: CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 18 UK: CELL CRYOPRESERVATION MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 19 REST OF EUROPE: CELL CRYOPRESERVATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 20 REST OF EUROPE: CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 21 REST OF EUROPE: CELL CRYOPRESERVATION MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 22 ASIA-PACIFIC: CELL CRYOPRESERVATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 23 ASIA-PACIFIC: CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 24 ASIA-PACIFIC: CELL CRYOPRESERVATION MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 25 JAPAN: CELL CRYOPRESERVATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 26 JAPAN: CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 27 JAPAN: CELL CRYOPRESERVATION MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 28 CHINA: CELL CRYOPRESERVATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 29 CHINA: CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 30 CHINA: CELL CRYOPRESERVATION MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 31 INDIA: CELL CRYOPRESERVATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 32 INDIA: CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 33 INDIA: CELL CRYOPRESERVATION MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 34 AUSTRALIA: CELL CRYOPRESERVATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 35 AUSTRALIA: CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 36 AUSTRALIA: CELL CRYOPRESERVATION MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 37 SOUTH KOREA: CELL CRYOPRESERVATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 38 SOUTH KOREA: CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 39 SOUTH KOREA: CELL CRYOPRESERVATION MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 40 REST OF ASIA-PACIFIC: CELL CRYOPRESERVATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 41 REST OF ASIA-PACIFIC: CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 42 REST OF ASIA-PACIFIC: CELL CRYOPRESERVATION MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 43 REST OF THE WORLD: CELL CRYOPRESERVATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 44 REST OF THE WORLD: CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 45 REST OF THE WORLD: CELL CRYOPRESERVATION MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 46 MIDDLE EAST: CELL CRYOPRESERVATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 47 MIDDLE EAST: CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 48 MIDDLE EAST: CELL CRYOPRESERVATION MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 49 AFRICA: CELL CRYOPRESERVATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 50 AFRICA: CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 51 AFRICA: CELL CRYOPRESERVATION MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 52 LATIN AMERICA: CELL CRYOPRESERVATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 53 LATIN AMERICA: CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 54 LATIN AMERICA: CELL CRYOPRESERVATION MARKET, BY END USER, 2019-2032 (USD BILLION)

LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL CELL CRYOPRESERVATION MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL CELL CRYOPRESERVATION MARKET
FIGURE 4 GLOBAL CELL CRYOPRESERVATION MARKET, SHARE (%), BY TYPE, 2023
FIGURE 5 GLOBAL CELL CRYOPRESERVATION MARKET, SHARE (%), BY APPLICATION, 2023
FIGURE 6 GLOBAL CELL CRYOPRESERVATION MARKET, SHARE (%), BY END USER, 2023
FIGURE 7 GLOBAL CELL CRYOPRESERVATION MARKET, SHARE (%), BY REGION, 2023
FIGURE 8 NORTH AMERICA: CELL CRYOPRESERVATION MARKET, SHARE (%), BY REGION, 2023
FIGURE 9 EUROPE: CELL CRYOPRESERVATION MARKET, SHARE (%), BY REGION, 2023
FIGURE 10 ASIA-PACIFIC: CELL CRYOPRESERVATION MARKET, SHARE (%), BY REGION, 2023
FIGURE 11 REST OF THE WORLD: CELL CRYOPRESERVATION MARKET, SHARE (%), BY REGION, 2023
FIGURE 12 GLOBAL CELL CRYOPRESERVATION MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
FIGURE 13 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS
FIGURE 15 VWR INTERNATIONAL LLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 VWR INTERNATIONAL LLC: SWOT ANALYSIS
FIGURE 17 STEMCELL TECHNOLOGIES INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 STEMCELL TECHNOLOGIES INC.: SWOT ANALYSIS
FIGURE 19 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 MERCK KGAA: SWOT ANALYSIS
FIGURE 21 GE HEALTHCARE LIFE SCIENCES.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 GE HEALTHCARE LIFE SCIENCES.: SWOT ANALYSIS
FIGURE 23 BIOLIFE SOLUTIONS INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 BIOLIFE SOLUTIONS INC.: SWOT ANALYSIS
FIGURE 25 AVANTOR INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 AVANTOR INC.: SWOT ANALYSIS
FIGURE 27 BIOCISION LLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 BIOCISION LLC: SWOT ANALYSIS
FIGURE 29 CESCA THERAPEUTICS INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 CESCA THERAPEUTICS INC.: SWOT ANALYSIS
FIGURE 31 CHART INDUSTRIES INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 CHART INDUSTRIES INC.: SWOT ANALYSIS
FIGURE 33 CUSTOM BIOGENIC SYSTEMS INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 34 CUSTOM BIOGENIC SYSTEMS INC.: SWOT ANALYSIS
FIGURE 35 WORTHINGTON INDUSTRIES INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 36 WORTHINGTON INDUSTRIES INC.: SWOT ANALYSIS
FIGURE 37 HAMILTON COMPANY: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 38 HAMILTON COMPANY: SWOT ANALYSIS
FIGURE 39 BECTON, DICKINSON AND COMPANY.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 40 BECTON, DICKINSON AND COMPANY.: SWOT ANALYSIS
FIGURE 41 BROOKS AUTOMATION INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 42 BROOKS AUTOMATION INC.: SWOT ANALYSIS
FIGURE 43 ZENOAQ RESOURCE CO. LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 44 ZENOAQ RESOURCE CO. LTD.: SWOT ANALYSIS
FIGURE 45 AIVITA BIOMEDICAL: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 46 AIVITA BIOMEDICAL: SWOT ANALYSIS

この商品のレポートナンバー

0000037982

TOP